Iovance Biotherapeutics, Inc. IOVA Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s increase (decrease) in prepaid expense and other assets?
- Iovance Biotherapeutics, Inc. (IOVA) reported increase (decrease) in prepaid expense and other assets of $1.47M in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
- Iovance Biotherapeutics, Inc.'s increase (decrease) in prepaid expense and other assets decreased by 54.9% year-over-year, from $3.25M to $1.47M.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.